Cargando…
Reversible Treatment of Pressure Overload‐Induced Left Ventricular Hypertrophy through Drd5 Nucleic Acid Delivery Mediated by Functional Polyaminoglycoside
Left ventricular hypertrophy and fibrosis are major risk factors for heart failure, which require timely and effective treatment. Genetic therapy has been shown to ameliorate hypertrophic cardiac damage. In this study, it is found that in mice, the dopamine D5 receptor (D5R) expression in the left v...
Autores principales: | Jiang, Xiaoliang, Shao, Meiyu, Liu, Xue, Liu, Xing, Zhang, Xu, Wang, Yuming, Yin, Kunlun, Wang, Shuiyun, Hu, Yang, Jose, Pedro A, Zhou, Zhou, Xu, Fu‐Jian, Yang, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927605/ https://www.ncbi.nlm.nih.gov/pubmed/33717857 http://dx.doi.org/10.1002/advs.202003706 |
Ejemplares similares
-
The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016) -
Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013) -
Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias
por: Chen, Xiaowei, et al.
Publicado: (2017) -
2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
por: Maayah, Zaid H., et al.
Publicado: (2018) -
DELAYED TREATMENT EFFECTS OF XANTHINE OXIDASE INHIBITION ON SYSTOLIC OVERLOAD-INDUCED LEFT VENTRICULAR HYPERTROPHY AND DYSFUNCTION
por: Xu, X., et al.
Publicado: (2010)